RA Capital Management - BLACK DIAMOND THERAPEUTICS I ownership

BLACK DIAMOND THERAPEUTICS I's ticker is BDTX and the CUSIP is 09203E105. A total of 59 filers reported holding BLACK DIAMOND THERAPEUTICS I in Q4 2022. The put-call ratio across all filers is 2.84 and the average weighting 0.0%.

Quarter-by-quarter ownership
RA Capital Management ownership history of BLACK DIAMOND THERAPEUTICS I
ValueSharesWeighting
Q3 2023$10,118,914
-43.2%
3,525,7540.0%0.20%
-40.8%
Q2 2023$17,805,058
+263.7%
3,525,754
+36.1%
0.34%
+202.7%
Q1 2023$4,894,919
+5.0%
2,589,9040.0%0.11%
+16.8%
Q4 2022$4,661,827
+6.5%
2,589,9040.0%0.10%
+2.2%
Q3 2022$4,377,000
-31.3%
2,589,9040.0%0.09%
-45.3%
Q2 2022$6,371,000
-11.2%
2,589,9040.0%0.17%
+8.3%
Q1 2022$7,174,000
-48.0%
2,589,9040.0%0.16%
-35.4%
Q4 2021$13,804,000
-37.0%
2,589,9040.0%0.24%
-20.1%
Q3 2021$21,911,000
-30.6%
2,589,9040.0%0.30%
-40.0%
Q2 2021$31,571,000
-49.8%
2,589,9040.0%0.51%
-46.5%
Q1 2021$62,831,000
-24.3%
2,589,9040.0%0.95%
-18.4%
Q4 2020$83,006,000
+6.0%
2,589,9040.0%1.16%
-19.0%
Q3 2020$78,293,000
-28.3%
2,589,9040.0%1.43%
-32.7%
Q2 2020$109,190,000
+69.0%
2,589,9040.0%2.13%
+4.3%
Q1 2020$64,618,0002,589,9042.04%
Other shareholders
BLACK DIAMOND THERAPEUTICS I shareholders Q4 2022
NameSharesValueWeighting ↓
Ally Bridge Group (NY) LLC 634,191$1,820,1282.14%
NEA Management Company, LLC 4,448,757$12,767,9330.99%
CHI Advisors LLC 720,000$2,066,4000.82%
Bellevue Group AG 8,135,839$23,349,8580.38%
Parkman Healthcare Partners LLC 520,587$1,494,0850.27%
Artal Group S.A. 2,046,517$5,8740.25%
RA Capital Management 3,525,754$10,118,9140.20%
Ikarian Capital, LLC 555,572$1,594,4920.19%
TANG CAPITAL MANAGEMENT LLC 400,000$1,148,0000.16%
Newtyn Management, LLC 205,000$588,3500.14%
View complete list of BLACK DIAMOND THERAPEUTICS I shareholders